News & Updates
Filter by Specialty:
Real-world data back CV safety of JAK inhibitors
Two real-world studies presented at EULAR 2023 reflected the cardiovascular (CV) safety of Janus kinase inhibitors (JAKi*) in patients with rheumatoid arthritis (RA).
Real-world data back CV safety of JAK inhibitors
28 Jun 2023
Breast cancer deaths highest within 5 years from diagnosis, decrease afterwards
The risk of mortality for women with early invasive breast cancer is highest during the 5 years after diagnosis, according to a study. Deaths from breast cancer will continue beyond this point, but such risk tends to decrease during each subsequent 5-year period.
Breast cancer deaths highest within 5 years from diagnosis, decrease afterwards
27 Jun 2023
COVID-19 pandemic immensely impacts mental health in postnatal women
A UK-based study demonstrated that the COVID-19 pandemic had an important negative impact on the mental health of postnatal women.
COVID-19 pandemic immensely impacts mental health in postnatal women
27 Jun 2023
Novel genetic marker predicts CHD risk in Chinese patients with T2DM
Researchers from the Chinese University of Hong Kong (CUHK) have discovered PDE1A rs10171703 as a novel genetic marker for coronary heart disease (CHD) in Chinese patients with type 2 diabetes mellitus (T2DM), indicating its potential utility for predicting CHD risk in this patient population.